Latest Ongoing Projects
Centre for Clinical Trials
A phase 3 Prospective, Randomized, Double-Masked, 12-week, parallel group Study evaluating the efficacy and safety of Latanoprost and Timolol in Pediatric subjects with Glaucoma [more info]
A randomized, double-masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trop-Eye in subjects with neovascular age-related [more info]
A phase 1, Open-Label study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated with Latanoprost 0,005% [more info]
Centre for Bioavailability Studies
CL3-20098-070 - Efficacy and safety of agomelatine oral administration (25 to 50 mg/day) in elderly patients suffering from Major Depressive Disorder [more info]
CL2-38093-009 - Safety and efficacy of S 38093 and donepezil, during 4 weeks, in patients with mild to moderate Azheimer’s Disease. An international, multi-centre, randomised, double-blind, placebo-controlled, phase II add-on study [more info]
Dosage of repaglinide in plasma samples from the BIA-91067-115 clinical trial of Bial. [more info]
Centre of New Technologies for Medicine
Evaluation of blood-retinal barrier functional alterations by optical coherence tomography [more info]
Retmarker - Critical Health / MA-Tracker [more info]
Ver + Saúde [more info]
Coimbra Coordinating Centre for Clinical Research
Prospective, randomized, open label phase II study to assess efficacy and safety of Macugen® (pegaptanib 0.3 mg intravitreal injections) plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy [more info]
Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis® monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis® plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy [more info]
Epidemiological study of the prevalence of Age-Related Macular Degeneration in Portugal [more info]